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Abstract
Background
While evidence from randomised controlled trials shows that telemonitoring for hypertension
is associated with improved blood pressure (BP) control, healthcare systems have been
slow to implement it, partly because of inadequate integration with existing clinical practices
and electronic records. Neither is it clear if trial findings will be replicated in routine clinical
practice at scale. We aimed to explore the feasibility and impact of implementing an inte-
grated telemonitoring system for hypertension into routine primary care.
Methods and findings
This was a quasi-experimental implementation study with embedded qualitative process
evaluation set in primary care in Lothian, Scotland. We described the overall uptake of tele-
monitoring and uptake in a subgroup of representative practices, used routinely acquired
data for a records-based controlled before-and-after study, and collected qualitative data
from staff and patient interviews and practice observation. The main outcome measures
were intervention uptake, change in BP, change in clinician appointment use, and partici-
pants’ views on features that facilitated or impeded uptake of the intervention. Seventy-five
primary care practices enrolled 3,200 patients with established hypertension. In an evalua-
tion subgroup of 8 practices (905 patients of whom 427 [47%] were female and with median
age of 64 years [IQR 56–70, range 22–89] and median Scottish Index of Multiple Depriva-
tion 2012 decile of 8 [IQR 6–10]), mean systolic BP fell by 6.55 mm Hg (SD 15.17), and
mean diastolic BP by 4.23 mm Hg (SD 8.68). Compared with the previous year, participating
patients made 19% fewer face-to-face appointments, compared with 11% fewer in patients
with hypertension who were not telemonitoring. Total consultation time for participants fell
by 15.4 minutes (SD 68.4), compared with 5.5 minutes (SD 84.4) in non-telemonitored
patients. The convenience of remote collection of BP readings and integration of these read-
ings into routine clinical care was crucial to the success of the implementation. Limitations
include the fact that practices and patient participants were self-selected, and younger and
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Conclusions
Telemonitoring for hypertension can be implemented into routine primary care at scale with
little impact on clinician workload and results in reductions in BP similar to those in large UK
trials. Integrating the telemonitoring readings into routine data handling was crucial to the
success of this initiative.
Author summary
Why was this study done?
• Although uncontrolled hypertension is the biggest remediable cause of stroke and myo-
cardial infarction, and anti-hypertensive medications are effective, many patients have
uncontrolled blood pressure (BP).
• Despite strong evidence that telemonitoring encourages medication use and is effective
at lowering BP, clinicians have been slow to adopt it, in part due to poor integration
with routine clinical processes.
• We wanted to see if an integrated telemonitoring system would be taken up by primary
care clinicians at scale, what impact this would have on their workload, and if changes
in BP would match those of randomised controlled trials.
What did the researchers do and find?
• Based on our previous research with clinicians on the desirable attributes of a telemoni-
toring system, NHS Lothian developed an integrated system that provided regular sum-
maries of patient home-monitored BP readings to their general practitioner, which were
delivered alongside routine laboratory results.
• We observed the rollout of this system, interviewing patients and clinicians about their
attitudes towards innovations to determine what worked and did not in terms increas-
ing uptake.
• In a group of 8 practices, we collected routinely acquired data on BP, clinician
appointments, and other resource use and compared these to the previous year.
Resource use was compared with patients in these practices with high BP who did not
use telemonitoring.
• We found that the intervention was popular in many but not all practices. Patients who
used the system had fewer appointments in the year of the intervention compared with
the previous year. BP fell in the intervention group, in line with findings of UK rando-
mised controlled trials.
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What do these findings mean?
• The findings suggest that introducing telemonitoring to routine practice at scale is
feasible.
• Although not definitive, the findings provide some reassurance that the intervention
did not increase practice workload and that in routine practice the improvements in BP
control were similar to those in controlled trials.
• However, the people who took part were not entirely typical of practice populations as a
whole, being on average younger and slightly more affluent.
• The findings support plans to introduce telemonitoring more generally, but within an
evaluative framework.
Introduction
Hypertension is common among people over the age of 50 years and is an important risk fac-
tor for cardiovascular disease [1]. Although effective management greatly reduces the risk of
cardiovascular events, blood pressure (BP) remains uncontrolled in many people [2]. This is in
part due to poor adherence to medication [3], but also reluctance on the part of clinicians to
intensify therapy [4] and on the part of patients to accept intensified therapy [5].
In the UK, hypertension is managed in primary care mainly by practice nurses assisted by
healthcare assistants with specific training in BP monitoring, supported by general practition-
ers (GPs). In Scotland (population 5.45 million), 1.2 million appointments in 2018 were taken
up solely for hypertension checks [6], despite evidence that home monitoring is a better pre-
dictor of long-term outcomes than office measurement [7]. Under the Scottish National
Health Service, all primary care attendances and medications are free at the point of contact,
paid for from general taxation. However, primary care is currently under considerable stress,
with falling numbers of GPs [8] and rising workload [9] as populations age and the prevalence
of hypertension increases. Technology has been promoted as a strategy for managing this
workload [10,11].
A number of trials have demonstrated that patient self-monitoring has a small but statisti-
cally significant effect on improving BP control [12]. Telemonitoring, however, which engages
clinicians in reviewing readings taken by patients and submitted over the internet or via short
message service (SMS), results in much larger clinically significant reductions in BP [13] and is
cost-effective [14,15]. Telemonitoring is associated with an intensification of medication [16],
and qualitative research has shown that this is because multiple persistently raised BP readings
convince both clinicians and patients that medication intensification and improved adherence
is required, thus overcoming ‘therapeutic inertia’ [5]. Supported self-monitoring enables
patients to act on physiological measures rather than on (perceived) symptoms such as head-
ache or fatigue [17].
Why then, given consistent findings from randomised controlled trials (RCTs), has tele-
monitoring not been more widely adopted? Implementing new models of care at scale is
challenging [18,19], particularly in the context of clinical teams already working at full
stretch. Telehealth trials have tended to recruit relatively few, often highly selected individu-
als who have then been followed up for relatively short periods, leaving unanswered ques-
tions about the day-to-day practicality of managing large numbers of patients [20]. In
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addition, the adoption, effectiveness, and impact on resources of delivering BP telemonitor-
ing as a routine approach to care are unknown and may differ from the experience in trials.
Following our earlier RCT of telemonitoring for uncontrolled hypertension [16], we sought
to investigate the acceptability and impact of introducing long-term telemonitoring across
NHS Lothian in southeast Scotland for people with previously diagnosed hypertension.
Methods
This study is reported in accordance with the Standards for Reporting Implementation Studies
(StaRI) [21]. This study was approved by the East of England–Cambridge South Research Eth-
ics Committee (16/EE/0058). We describe the deployment and uptake of telemonitoring gen-
erally and then the evaluation of the impact of the implementation in 8 practices chosen to
represent a range of size, deprivation, and earlier and later adopter of the technology.
Setting
The study was carried out in Lothian, Scotland (population 858,000). This region of Scotland,
which contains Edinburgh, the capital of Scotland, is mainly urban, with a mix of small towns,
suburban areas, inner city, and some rural areas. There are a range of levels of affluence and
deprivation.
The Scale-Up BP telemonitoring system and deployment
Logic model. The logic model for the Scale-Up BP deployment is illustrated in Fig 1, with
primary (implementation and health) outcomes and process outcomes mapped to the mecha-
nism by which the Scale-Up BP implementation strategy and telemonitoring was anticipated
to work.
The telemonitoring intervention implemented is presented in detail in S1 Text and S1 Fig.
Participating people with hypertension were provided with an electronic oscillometric sphyg-
momanometer and shown how to submit BP readings via a low-cost third-party text-based
telemonitoring system (Florence) [22] using their own mobile phone. These readings were
Fig 1. This logic pathway illustrates how the Scale-Up BP implementation strategy was expected to work. The primary outcomes are in white font on a
dark blue (implementation outcomes) or dark green (health outcome) background. The distinction is made between the evidence-based intervention (BP
telemonitoring) (yellow field) and the Scale-Up BP implementation strategy used to implement BP telemonitoring in routine practice (blue field). BP, blood
pressure; HBP, high blood pressure.
https://doi.org/10.1371/journal.pmed.1003124.g001
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stored in a central server and made available to practices via an internet link. However, previ-
ous research had shown that a major barrier to adoption was the need for clinicians to log on
to third-party websites during busy clinics [20], and so a novel element [23] was developed
that automatically extracted patient-generated data from the third-party website. This element
displayed a mean BP and summarised BP values in graphical and tabular format (S2 Fig) and
dispatched these summaries, at intervals chosen by the clinician, through the routinely used
primary care data management system, Docman [24]. This obviated the need for third-party
log-ons and, critically, systematically presented the telemonitoring results in manageable
numbers on a daily basis, with relatively infrequent but data-rich reports integrated into the
electronic medical record and seen alongside routine laboratory results and hospital commu-
nications. Between reports, patients were informed by automated text responses if submitted
readings were low, normal, high, or very high and were advised to follow a written action plan
with respect to contacting their practice either routinely or urgently as appropriate.
The Scale-Up BP implementation project was launched in June 2015 and continues. The
Scottish Government’s Technology Enabled Care (TEC) Programme [25] financed the third-
party telemonitoring service, the development of the software to link it with primary care sys-
tems using Docman, supported facilitators to visit/train practices, and purchased sphygmoma-
nometers for loan to patients.
Recruitment of practices. All 126 Lothian practices were invited to participate via a
weekly newsletter. Practices expressing interest were followed up with information visits and
training if they participated.
The Scale-Up BP implementation strategy
The implementation strategy was informed by barriers and facilitators identified in previous
research as important to clinicians [20,26] and utilised elements of ‘COM-B’ behaviour change
[27] and diffusion of innovation theories [28]. S1 Table lists how these barriers were addressed.
In essence the approach comprised the following: motivating clinicians and service planners
by demonstrating how an evidence-based BP telemonitoring service could improve outcomes
and potentially save time; enhancing capability by providing initial training and (importantly)
retraining and ongoing support as required; and providing opportunity by supporting recruit-
ment drives within individual practices. Local practitioner ‘champions’ were recruited to be
early adopters in the expectation that they would demonstrate and promote the intervention
to colleagues [29]. Practices were encouraged to adapt the system to suit their routines and
priorities, with flexibility in terms of the initial patient groups targeted (some focusing on
uncontrolled hypertension). Clinicians were continuously involved in the development of the
implementation strategy, trialling different recruitment methods and different approaches to
managing telemonitoring data. Learning from practices was shared in regular newsletters.
Outcomes of interest
Our primary implementation outcomes were the number of participating practices and the
overall number of patients recruited. In addition, in a subgroup of 8 practices, chosen to
represent a range of socioeconomic status, practice size, city centre/small town, and fast/slow
patient recruitment, we measured patient engagement and adherence, resource and medica-
tion use, and BP change over time, and gauged clinician and patient acceptability of the
implementation.
These practices agreed to allow data on BP, anti-hypertensive medication prescriptions,
and practice workload (as recorded in the appointment system) for all patients with hyperten-
sion (including those not being managed by the Scale-Up BP system) to be extracted from
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their electronic health record, linked to data from the telemonitoring system, de-identified,
and transferred to the local NHS safe haven (a secure analysis server that does not permit any
data to be taken away).
This allowed comparison of resource use between participating and non-participating
patients. Primary care stored data were collected and transferred by a data extraction service
(Albasoft) through software already resident on the practice computers. Time to action for
very high (>160 mm Hg) and very low (<90 mm Hg) average systolic BP readings was
obtained from manual searching of Docman reports and practice records. Change in BP over
time was derived from telemonitored data from Scale-Up BP patients only.
As the purpose of the study was primarily to determine uptake of the intervention, a formal
power calculation was not deemed appropriate.
Assessment of attrition
Patients were considered to have discontinued monitoring if they did not record any readings
for 7 months during the observation period. This period was chosen because we did not want
to exclude patients with good BP control, some of whom were asked to submit readings only
every 6 months.
A logistic mixed regression analysis was performed on the discontinuation outcome to help
us identify the characteristics of patients who had discontinued. The variables female sex, sec-
ond telemonitored systolic BP, Scottish Index of Multiple Deprivation (SIMD) [30]� 5 (less
deprived), and age were included in the model, which was also adjusted for GP practice as a
random effect. The continuous variables systolic BP and age were initially fitted as having a
continuous (linear) relationship with the probability of discontinuation, but this assumption
was subsequently relaxed in sensitivity analysis, whereby we used flexible natural B-spline
functions to model the relationship between these variables and the probability of discontinua-
tion. The modelled relationships were then displayed graphically in line plots.
Practice workload and resource use
We collected data on (i) the total number of appointments, (ii) total number of face-to-face
appointments, (iii) total consultation time, and (iv) total consultation time in the surgery.
The practice appointment system was used to identify all interactions including face-to-face
and planned telephone consultations, home visits, and administration activities (for example,
prescribing a requested repeat prescription). Face-to-face consultations could be reliably iden-
tified as they had different arrival and start times. We determined time spent in activities
recorded in the appointment system in total and in face-to-face activities for all people with
hypertension in the 8 practices and could compare those taking part in the intervention with
those who were not.
There was no automated extraction method that could determine time spent in consulta-
tions that were not recorded in the appointment system such as ad hoc phone calls or record
checking.
Analysis of resource use outcomes was conducted by computing totals/averages across all
patients and comparing before and after Scale-Up BP implementation, and separately per-
forming a patient-level analysis by computing sum totals/averages within patients. We only
included patients with a full year of data before and after the first recorded telemonitored read-
ing. Regarding the consultation time analysis, the first analysis weighted patients with a greater
number of appointments more heavily than the second patient-level analysis did, which is
appropriate when simply trying to give an overall impression of resource use burden. On the
other hand, the second analysis takes a within-patient approach to ascertain if consultation
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times have changed at the patient level, after properly accounting for clustering by patient.
Both sets of analyses are complementary in allowing us to provide a full and clear presentation
of the resource use data.
The telemonitored patients’ appointment data were compared against comparator patients
(all patients with a diagnosis of hypertension who did not use the telemonitoring system) from
the same 8 evaluation practices. For the comparator group, we could not choose the start of tel-
emonitoring as the ‘anchor point’ to define the before and after groups, we therefore used a
randomly chosen date for the anchor point within a date range consistent with patient telemo-
nitoring start times in the telemonitoring group (between October 2015 and June 2016). Out-
lier consultation durations (>30 minutes, which is 3 times the length of a typical primary
consultation in the UK) were excluded from all analyses involving consultation time as these
are very likely to be erroneous, and so it was not appropriate to retain them in the analyses.
These long consultation times are almost certainly because clinicians failed to close the elec-
tronic record, for example before taking breaks or starting other tasks. It would be very
unlikely that a consultation related to BP management would be so long; including these
would lead to an overestimate of resource use.
Linear mixed effects models were then fitted to the resource use outcomes to compare
telemonitored patients with the comparator group, adjusting for female sex, SIMD� 5 (less
deprived), initial surgery-measured systolic BP (after September 2015), age (in years), and GP
practice as a random effect. As was the case for the attrition analysis, natural B-spline functions
were used to model the effects of age and systolic BP on the outcome.
Change in BP over 6 months and proportion of patients with controlled BP
The difference between the second telemonitored BP reading (baseline) and the last BP read-
ing, occurring 6–12 months after the second telemonitored reading, was calculated for each
patient (second minus last). We used the second telemonitored reading because the first was
sometimes taken in the GP practice as a demonstration of the system to the patient, and there
is a known disparity between home and office BP readings. Only patients with a full year’s fol-
low-up were included. Summary statistics (mean, median, standard deviation, lower quartile,
upper quartile, minimum, and maximum) were calculated based on these BP differences, over-
all and stratified by age, sex, SIMD, and second telemonitored BP.
To assess the proportion of patients whose hypertension was uncontrolled, as defined by
National Institute for Health and Care Excellence guidelines [31] (home systolic BP� 135 mm
Hg), we categorised the BP data according to level of control of BP, and compared the propor-
tions with uncontrolled hypertension at baseline with the proportion 6–12 months later.
Patients were only included in this analysis if they had complete data at baseline and 6–12
months.
Assessment of medication prescribed
For each patient, we calculated the total number of anti-hypertensive medication prescriptions
in the year before the patient first started telemonitoring and in the year after. To avoid bias,
we only included patients with a full year of data before and after the start of telemonitoring.
Summary statistics were then computed overall and stratified by age, sex, SIMD, and initial
systolic BP. SAS software version 9.4 (SAS Institute, Cary, NC, US) was used to analyse the
data.
Mean defined daily dose (DDD) was calculated for the 6 months before and after date of
the first telemonitored reading for all patients with at least 6 months of follow-up, based on
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WHO DDD index values [32], and compared using a paired t test (analysis undertaken in R
version 3.5.3).
Qualitative exploration of patient and professional perceptions
In the 8 evaluation practices, we undertook semi-structured face-to-face interviews with
patients, GPs, practice nurses, and healthcare assistants, to explore perceptions of the telemo-
nitoring intervention in terms of ease of use, organisational adoption and adaptation, barriers,
facilitators, and potential improvements to the implementation of Scale-Up BP. See S2 Text
for details of methodology.
Results
Progress of the implementation: Practice and patient recruitment
The number of participating practices throughout Lothian grew steadily following the launch,
and by July 2019 (45 months after the start of the project) 75/126 practices in Lothian had par-
ticipated. Patient recruitment accelerated as new practices were trained, reaching a total of
3,200 patients by July 2019 (S3 Fig). Practices differed greatly in terms of the numbers of
patients they recruited (range 6–400). Some required several training sessions before com-
mencing recruitment. The most successful recruiting practices systematically invited all their
patients with hypertension to register. Two practices had evening group meetings. Others,
with highly motivated clinical staff, were very successful at recruiting patients during routine
attendances. In some practices, clinicians were selective about to whom they offered the inter-
vention. For example, initially, when they had less experience with the system, they tended to
offer it to patients whom they thought would be most likely to manage self-monitoring. Some
practices focused initially on uncomplicated patients with controlled BP, while others chose
patients with less well controlled BP.
Patient population
In the 8 evaluation practices, of the 905 patients signed up to use the telemonitoring system
and providing BP data, 427 were female (47%), and the patients had a median age of 64 years
(IQR 56–70, range 22–89) and median SIMD 2012 decile of 8 (IQR 6–10). The individuals in
the comparator group were older on average (median age 71 years, IQR 62–79, range 20–90),
had a slightly higher percentage of females (54%), and were slightly less affluent on average
(median SIMD of 7). Initial systolic BP reading was similar between groups (see Table 1). The
median number of patients using the telemonitoring system per practice was 80 (IQR 44 to
153), compared to 450 (IQR 332 to 599) controls. Apart from being slightly more affluent, gen-
erally the evaluation practices were representative of practices in Lothian (see Table 2).
Table 1. Patient characteristics in the telemonitoring and comparator groups.
Characteristic Telemonitoring group (n = 905) Comparator group (n = 9,061)
Female sex 427/905 (47%) 4,934/9,061 (54%)
Age of patient in 2015 (years)� Median 64 (IQR 56 to 70, min 22, max 89,
n = 905)
Median 69 (IQR 60 to 79, min 19, max 90,
n = 8,610)
SIMD 2012 decile Median 8 (IQR 6 to 10, min 2, max 10, n = 888) Median 7 (IQR 5 to 10, min 1, max 10, n = 8,957)
Initialsystolic blood pressure reading in the surgery (after
September 2015)
Median 140 (IQR 130 to 150, min 90, max 200,
n = 877)
Median 138 (IQR 129 to 149, min 71, max 240,
n = 7,694)
�The exact date of birth was not available because of data governance reasons.
max, maximum; min, minimum; SIMD, Scottish Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003124.t001
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Patient engagement
We explored patient engagement during the period 2 September 2015 to 7 January 2018 in
the 8 evaluation practices. Of 905 patients signed up to use the telemonitoring system and
providing BP data, a median of 28 (IQR 14 to 76) BP readings were submitted in total per
patient, although many of these patients were only recently recruited and had varying
lengths of follow-up. Excluding patients with less than 1 year of follow-up, the remaining
430 patients submitted a median of 42 readings in 1 year (IQR 22 to 94), with 359/430
patients (83%) submitting over 20 readings and 97/430 patients (23%) submitting over 100
readings (see S4 Fig).
Patient attrition
Of the 655 patients who had been enrolled in telemonitoring for more than 7 months, 49 (7%)
stopped texting readings. Sex, age, or SIMD did not significantly predict discontinuing (see S2
Table). However, patients with higher systolic BP were more likely on average to discontinue
(odds ratio 1.03, 95% CI 1.01 to 1.05). S5 and S6 Figs show how the predicted probability of
dropout varies with systolic BP and age when these variables are fitted using flexible spline
functions and are not constrained to be linear in the statistical model.
Change in resource use over time
According to records in the appointment system, there were 1,260 appointments in total (671
face-to-face) in the year before the start of telemonitoring, compared to 1,158 appointments
in total (569 face-to-face) in the year after. This corresponded to an observed 8% reduction in
total appointments, and a 15% reduction in the number of face-to-face appointments.
There was an observed increase in appointments just prior to the start of telemonitoring,
probably due to patients attending for training to measure BP and text results, which might
potentially exaggerate potential reductions in consultation numbers (see S7 Fig). In further
analysis, in comparing changes in resource use with a comparator group of non-participating
patients, we therefore excluded consultations within 2 weeks of the anchor point, which for tel-
emonitoring patients may have involved appointments to set up the system. We also excluded
7% of consultations for which the appointment times were not recorded and an additional 3%
of consultations that were recorded as being over 30 minutes in duration.
Table 2. Descriptive statistics for evaluation practices compared to non-evaluation practices in NHS Lothian.
Characteristic Non-evaluation practices (n = 117) Evaluation practices (n = 8)
Percentage female 50.7% (50.0% to 51.5%) 51.0% (50.7 to 51.5%)
Percentage 25–44 years old 28.5% (25.3% to 36.1%) 27.1% (25.6% to 36.7%)
Percentage 45–64 years old 27.0% (24.2% to 28.6%) 27.6% (18.6% to 29.2%)
Percentage 65+ years old 16.0% (12.7% to 19.5%) 17.3% (10.6% to 20.6%)
Percentage SIMD < 5 (more deprived) 31.5% (12.2% to 50.7%) 22.9% (12.1% to 38.3%)
Modal urban/rural classification Large urban areas, 68 (59%)
Other urban areas, 23 (20%)
Accessible small towns, 12 (10%)
Accessible rural, 8 (7%)
Remote small towns, 5 (4%)
Large urban areas, 5 (62%)
Other urban areas, 2 (25%)
Accessible small towns, 1 (12%)
Accessible rural, 0 (0%)
Remote small towns, 0 (0%)
Results are expressed as median (interquartile range), except modal urban/rural classification, which is presented as
frequency (percentage).
SIMD, Scottish Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003124.t002
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Both the comparator group and telemonitoring group showed decreases in numbers of
all appointments and face-to-face appointments. Decreases in the number of appointments
were notably more pronounced in the telemonitored group than in the comparator group for
females, relatively more deprived (SIMD< 5) individuals, and people whose BP was controlled
(see S3 Table).
Table 3 shows the number of consultations and consultation length for the participant and
comparator groups for the year before and after the intervention. A total of 118 telemonitoring
patients were included with at least 1 consultation recorded before and after the intervention.
As above, we excluded consultations within 2 weeks of the anchor point. Among these 118
patients, 46 (39%) were female, and they had a median age of 64 years (IQR 54 to 69), median
SIMD of 9 (IQR 7 to 10), and mean initial surgery-measured systolic BP value of 139.4 mm Hg
(SD 16.0). The patient characteristics of the comparator group were as shown in Table 1.
Therefore, the difference in demographics between telemonitoring and control patients were
more pronounced than for the overall cohort, except average initial systolic BP value, which
was very similar between groups.
Mixed effects models were fitted to the outcomes to compare telemonitored patients with
the comparator group, adjusting for SIMD category (<5 or�5), age, sex, and initial systolic
BP (see S4 Table). Time spent in all appointments in the year was significantly reduced in the
telemonitoring group (adjusted mean difference 16.1 minutes, 95% CI 0.1 to 32.1 minutes,
p = 0.048). Although the reduction in time spent in face-to-face appointments did not achieve
statistical significance, the observed reduction was clinically relevant (12.7 minutes, 95% CI
−0.5 to 25.9 minutes, p = 0.059). Note that confidence intervals were wide due to the relatively
small sample size in the telemonitoring group. There was no significant difference in total
number of appointments (face-to-face or overall) in the adjusted analysis.
Change in BP over time
During the study period, there were 399 patients in the 8 evaluation practices who had at least 1
year of follow-up and 2 telemonitored BPs at least 6 months apart. This group had similar initial
Table 3. Change in total and face-to-face appointment numbers and consultation length in people with hypertension participating and not participating in
telemonitoring.
Outcome Variable Telemonitoring group (n = 118) Comparator group (n = 9,061)
Median Lower
quartile
Upper
quartile
Median Lower
quartile
Upper
quartile
Number of appointment activities per patient Before 6.5 4 14 7 4 14
After 6 4 13 7 3 14
Reduction (before minus
after)
0 −3 4 0 −4 4
Number of face-to-face consultations per patient Before 5 3 9 4 1 8
After 4 2 7 4 1 7
Reduction (before minus
after)
1 −2 3 0 −2 3
Consultation time per patient all appointments
(minutes)
Before 67.5 30 129 64 27 123
After 49.5 25 103 59 23 116
Reduction (before minus
after)
14 −25 53 4 −32 39
Face-to-face consultation time per patient
(minutes)
Before 63 27 104 47 15 97
After 41 19 82 42 10 88
Reduction (before minus
after)
15 −18 48 0 −23 34
https://doi.org/10.1371/journal.pmed.1003124.t003
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surgery-measured systolic BP readings compared to other hypertension patients in the practices
who had not been telemonitored (who also had at least 2 BP readings at least 6 months apart).
However, there was a lower percentage of females in the telemonitoring group than in the com-
parator group, patients were younger on average, and had a higher median SIMD decile on
average (median 9 versus 7), indicating a more affluent population (see Table 4).
The median difference between the second telemonitored BP and the last was 6 mm Hg
(IQR −3 to 15) for systolic BP and 4 mm Hg (IQR −1 to 10) for diastolic BP. Decreases in BP
were greater for those whose BP was initially uncontrolled: People whose systolic BP was�135
mm Hg had a median reduction in BP of 13 mm Hg (IQR 6 to 23), whereas people whose BP
was<135 had no change in the median BP (IQR −7 to 7). This reduction in systolic BP was
consistent across age, sex, and deprivation (see S5 Table), and was reflected in the proportion
achieving control of hypertension (see Table 5).
Fig 2 shows how mean BP changed over time for 185 people who recorded at least 1 BP
reading per month for 12 months after the start of telemonitoring. The relative variability in
the mean between groups and over time is represented in the plot by vertical error bars (±1
standard error). A similar plot based on the full n = 399 is shown in S8 Fig, which shows a
very similar relationship over time. (Note that the data are not completely paired in S8 Fig as
some patients did not record monthly readings continuously and so the points are not joined
together).
Clinician responsiveness to high BP readings
We searched the Docman reports in the 8 practices for instances where BP control was poor
and would normally result in management changes. We found 44 instances of average systolic
BP> 160 mm Hg and 3 instances of an average systolic BP < 90 mm Hg in Docman reports.
Table 4. Patient characteristics in the telemonitoring and comparator groups who had at least 1 year of follow-up and 2 blood pressure readings at least 6 months
apart.
Characteristic Telemonitoring group (n = 399�) Comparator group (n = 3,484�)
Female sex 182/399 (46%) 1,845/3,484 (53%)
Age (years) Median 64 (IQR 56 to 70, min 29, max 89) Median 71 (IQR 62 to 79, min 20, max 90)
SIMD 2012 decile Median 9 (IQR 6 to 10, min 2, max 10) Median 7 (IQR 5 to 10, min 1, max 10)
Initial systolic blood pressure reading in the surgery (after September
2015)
Median 138 (IQR 128 to 150, min 100, max
188)
Median 138 (IQR 130 to 150, min 71, max
240)
�SIMD decile and systolic blood pressure were based on n = 392 in the telemonitoring group. SIMD decile was based on n = 3,436 in the comparator group.
max, maximum; min, minimum; SIMD, Scottish Index of Multiple Deprivation.
https://doi.org/10.1371/journal.pmed.1003124.t004
Table 5. Number (percent) of patient participants with various levels of uncontrolled hypertension at baseline
and follow-up.
Blood pressure reading Second telemonitored reading Last telemonitored reading (6–12 months later)
SBP� 135 mm Hg 190/399 (48%) 94/399 (24%)
SBP� 140 mm Hg 138/399 (35%) 51/399 (13%)
SBP� 145 mm Hg 92/399 (23%) 37/399 (9%)
SBP� 150 mm Hg 62/399 (16%) 20/399 (5%)
DBP� 85 mm Hg 138/399 (35%) 66/399 (17%)
DBP� 90 mm Hg 90/399 (23%) 23/399 (6%)
DBP, diastolic blood pressure; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pmed.1003124.t005
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The median number of days from first systolic BP > 160 mm Hg or <90 mm Hg appearing
in the medical record (transcribed from the Docman report) to clinical review and action (or
not) was 13 (range 0–91 days). Actions recorded in the primary care records occurring in
response to these reports are summarised in S6 Table.
Change in number of anti-hypertensive medications prescribed
For 622 patients taking part in Scale-Up BP for 1 year, we calculated average DDD of BP-low-
ering medications in the 45 days before they started telemonitoring and, to allow for discovery
of a raised BP and time to respond to it, for a similar period 4–6 months after they started tele-
monitoring. Average DDD rose from 2.08 to 2.35 between those timepoints, a rise of 12% (See
S7 Table). Additionally, there was a small increase in the total number of prescriptions issued
for anti-hypertensive medications to patients over the whole year (1.06 [SD 4.77] additional
prescriptions). Prescription numbers increased more in people whose baseline BP was >135
mm Hg and who were from more deprived areas. Similar changes were found in patients with
raised BP not taking part in Scale-Up BP (see S8 Table).
Fig 2. Line plot showing systolic blood pressure change over time in 185 people who had at least 1 blood pressure reading per month for 12 months
after the start of telemonitoring.
https://doi.org/10.1371/journal.pmed.1003124.g002
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Perceptions of the implementation
Details of the process evaluation including observation of the implementation process and
interviews with clinicians and patients can be found in S3 Text, S9 and S10 Tables. In sum-
mary, clinicians found that getting regular reports integrated with their usual data handling
practices was particularly helpful. Continued support from the implementation team, the
involvement of local champions, and patient enthusiasm for the service were all instrumental
in building confidence in the process. Initially, starting patients on the system was seen as time
consuming, but this improved with time and was perceived as balanced by subsequent time
saving. Practice teams adapted aspects of the intervention, particularly data handling, to their
own routines.
Discussion
Summary of findings
This study shows that a telemonitoring system for BP monitoring using software to integrate it
with normal primary care work patterns can be implemented at scale. BP control improved, in
line with results found in RCTs of telemonitoring, probably mediated by an intensification in
therapy [16,33–36]. This new model of care was associated with an observed reduction in the
number of face-to-face appointments and consulting time. The well-recognised barriers to
implementation of new technologies (lack of confidence in technology, workload fears, lack of
time to learn and introduce new things, and scepticism that the implementation will improve
patient care or efficiency) were overcome through engaging frontline clinicians in the develop-
ment of the system, particularly local champions, and strong continuous support from a facili-
tator team. While it was relatively straightforward to persuade practices of the likely benefits of
the intervention and to undertake training, they varied in translating that training into action.
Some practices required several training sessions before they started regular recruitment,
while some did not get started at all, usually citing lack of time. Others, however, recruited
large numbers of patients to the project, and their success persuaded other practices to follow
them. Patients liked the system, and relatively few discontinued; however, it is concerning that
people with less well controlled BP were overrepresented among those who discontinued, and
this requires further investigation.
Strengths and limitations
This intervention was implemented in typical primary care practices by clinical staff for
patients for routine care purposes rather than in a research setting. Integration with practice
data management routines and the ability to adapt the intervention encouraged uptake by
practices and, apart from initial training and remote technical support, needed little additional
support. The use of routine data sources means that any evaluation can be continued in future
to determine the longer-term effects of the intervention.
The Scale-Up BP patients in the 8 evaluation practices were self-selected or chosen by clini-
cal staff; they were slightly less deprived and younger on average than others in the practices
with hypertension and may have been more able to participate in terms of self-management,
or more motivated. Nonetheless, older and more deprived participating patients benefitted
equally or more from the intervention. A component of the large reduction in BP (15 mm Hg)
over time for patients who initially had uncontrolled hypertension could be considered as
regression to the mean, but this was a largely unselected group in terms of BP control, and the
reduction in overall mean is unlikely therefore to be a totally random effect. However, the pur-
pose of our study was not to prove effectiveness (as this has already been established) [13] but
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to show that telemonitoring can be implemented at scale. It is reassuring that the reduction in
mean systolic BP was similar to or exceeded those of the intervention groups in UK RCTs with
similar patient characteristics and that showed significant reductions in BP compared to a con-
trol group [16,33–36] (see S11 Table).
Patients were texting in their BP readings, and this could have been a source of bias. How-
ever, our previous work [37] showed that end-digit and target preference by patients, if it
occurred, was relatively trivial and considerably less than is found in office measurements [38].
Although overall contact time and face-to-face appointments fell both in absolute terms and in
comparison with people with hypertension who were not participating in telemonitoring, time
spent dealing with abnormal reports in an ad hoc way that did not involve the appointment
system was harder to capture. However, practices with large numbers of patients on the tele-
monitoring system believed that it was saving them time. Additionally, we did not capture the
time spent by clinicians in the evening recruitment meeting. However, these lasted around 90
minutes, involved 2 clinicians, and typically recruited around 70 patients, so were very time
efficient.
The sample size of telemonitoring patients with valid resource use data was quite small
(n = 118) in comparison to the n = 430 patients in the telemonitoring group with a full year of
follow-up, perhaps reflecting difficulties in capturing resource use data. Caution is therefore
needed when seeking to generalise the descriptive data to a wider population. Our use of a con-
trol group was important in this situation so that we had valid comparators whose data were
collected under the same conditions.
Discussion in relation to published literature
Previous studies of telemonitoring have been in the context of RCTs with practices contribut-
ing relatively small numbers of patients that are relatively easy to manage. In this study some
practices were recruiting hundreds of patients. Systematic reviews of telemonitoring of hyper-
tension suggest that it is effective [15] in reducing BP, but that the effectiveness depends on
the intensity of the intervention [13]. The most effective systems were similar to Scale-Up BP.
Methods of assessing change in BP vary from study to study, but those using research nurse
clinic measurements demonstrated reductions similar to those in Scale-Up BP for patients
whose baseline BP was uncontrolled. There have been no direct trials to our knowledge explor-
ing the impact of telemonitoring on cardiovascular outcomes, but based on previous studies
of anti-hypertensive agents, BP reductions of the magnitude achieved in this study, probably
through intensification of anti-hypertensive therapy, if sustained, would be expected to lead to
a greater than 15% reduction in risk of stroke and a greater than 10% reduction in risk of coro-
nary heart disease [39].
Implications for policy, practice, and future research
Telemonitoring of hypertension has been shown to be cost-effective [14,15]. Sphygmomanom-
eters have become less expensive in recent years and in Lothian will in future be provided by
the Health Board. Low-cost telemonitoring systems have become available, potentially lower-
ing costs further. We believe that the integrated system we tested will improve efficiency. The
system has recently been adopted by the Scottish Government, with plans to roll it out across
the country. Further work is underway to determine the optimum strategies to enrol patients
in the system and to get them to adhere to it. Further integration with the primary care medical
record and making the reports available to secondary care is planned, as is the development
of an app-based solution and improved asynchronous communication with patients. An eco-
nomic evaluation will be the subject of a future paper.
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Conclusion
Scale-Up BP has demonstrated that improvements in BP control similar to those found in
RCTs of telemonitoring in hypertension can be achieved when implemented in routine prac-
tice and at scale and that this is accomplished with no increase in workload. The strategy of
integrating the telemonitoring system with current data handling routines was critical in the
adoption and is a model for managing other long-term conditions. Based on the findings from
this implementation study, we conclude that Scale-up BP is ready for routine use across NHS
Scotland and possibly also other parts of the UK.
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